Search
Matinas BioPharma Holdings Inc
MTNBAdd to Watchlist
0.290USD
-0.027-8.57%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.71MMarket Cap
LossP/E TTM
MTNB Financials
See Matinas BioPharma Holdings Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Matinas BioPharma Holdings Inc Earnings Date
Latest Release
May 8, 2026
EPS / Forecast
-0.30/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.00
59.82%
Analyst Rating
2025/06/28
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2025 earnings report, its current assets were 4.08M, with a year-on-year change of -49.22.
What are the total assets of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2025 earnings report, its total assets of Matinas BioPharma Holdings Inc were 7.21M, with a year-on-year change of -42.98.
What are the total liabilities of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2025 earnings report, its total liabilities of Matinas BioPharma Holdings Inc were 2.38M, with a year-on-year change of -52.92.
What is the total equity of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2025 earnings report, its total equity of Matinas BioPharma Holdings Inc was 4.83M, with a year-on-year change of -36.36.
What is the net operating income of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2025 earnings report, its net operating income of Matinas BioPharma Holdings Inc was -6.96M, with a year-on-year change of 65.48.
What is the net investment of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2025 earnings report, its net investment of Matinas BioPharma Holdings Inc was 335.00K, with a year-on-year change of -96.36.
What is the net financing of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2025 earnings report, its net financing of Matinas BioPharma Holdings Inc was 3.39M, with a year-on-year change of -63.04.
What is the Earnings Per Share (EPS) of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.00, with a year-on-year change of 59.82.
What is the net income of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2025 earnings report, its net income was -10.96M, with a year-on-year change of 54.79.
What is the debt-to-asset ratio of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2025 earnings report, its debt-to-asset ratio was 0.10, with a year-on-year change of -27.78.
What is the Return on Equity (ROE) of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2025 earnings report, its Return on Equity (ROE) was -176.54, with a year-on-year change of 2.32.
What is the Return on Assets (ROA) of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2025 earnings report, its Return on Assets (ROA) was -104.24, with a year-on-year change of 18.88.
What is the operating profit of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2025 earnings report, its operating profit was -6.96M, with a year-on-year change of 65.48.